Naposomes: A new class of peptide-derivatized, target-selective multimodal nanoparticles for imaging and therapeutic applications (408 views)
Ther Deliv (ISSN: 2041-5990), 2011 Feb; 2(2): 235-257.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 0, 5-year impact factor: 0
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-79954479044&partnerID=40&md5=736a90e7eed662b18b9d9e9a0e8e3f83
Keywords: 7-14 Bombesin, Amphotericin B, Amphotericin B Lipid Complex, Chelating Agent, Cholecystokinin A Receptor, Cholecystokinin B Receptor, Cholecystokinin Octapeptide, Cyclophosphamide, Daunorubicin, Docetaxel, Doxorubicin, Gadolinium Diethylenetriamine Pentaacetic Acid, Gadolinium Pentetate, Gadoteridol, Liposome, Monomer, Nanoparticle, Naposome, Nuclear Magnetic Resonance Imaging Agent, Octroscan, Paclitaxel, Pentetreotide In 111, Peptide Derivative, Polysorbate 80, Unclassified Drug, Vincristine, Breast Cancer, Cardiotoxicity, Cell Proliferation, Drug Determination, Drug Dosage Form Comparison, Drug Efficacy, Drug Formulation, Drug Receptor Binding, Drug Safety, Encapsulation, Flow Cytometry, Gastrointestinal Symptom, Human, Hydrophobicity, Lung Metastasis, Lymphoma, Melanoma, Micelle, Molecular Weight, Nervous System Tumor, Neuroendocrine Tumor, Nonhuman, Particle Size, Priority Journal, Contrast Media, Drug Delivery Systems,
Affiliations:
*** IBB - CNR ***
Department of Biological Sciences and CIRPeB, University of Naples Federico II, Via Mezzocannone 16, 80134 Naples, Italy
References:
Gregoriadis, G., Ryman, B.E., Lysosomal localization of fructofuranoside-containing liposomes injected into rats (1972) Biochem. J., 129, pp. 123-13
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review (2000) Journal of Controlled Release, 65 (1-2), pp. 271-284. , DOI 10.1016/S0168-3659(99)00248-5, PII S0168365999002485
Bajoria, R., Contractor, S.F., Effect of surface charge of small unilamellar liposomes on uptake and transfer of carboxyfluorescein across the perfused human term placenta (1997) Pediatric Research, 42 (4), pp. 520-527
Miller, C.R., Bondurant, B., McLean, S.D., McGovern, K.A., O'Brien, D.F., Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes (1998) Biochemistry, 37 (37), pp. 12875-12883. , DOI 10.1021/bi980096y
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., Fujiwara, H., Mayumi, T., Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins (1997) Biochemical and Biophysical Research Communications, 240 (3), pp. 793-797. , DOI 10.1006/bbrc.1997.7749
Scherphof, G.L., Kamps, J.A.A.M., Receptor versus non-receptor mediated clearance of liposomes (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 81-97. , DOI 10.1016/S0169-409X(97)00133-6, PII S0169409X97001336
Papisov, M.I., Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 119-138. , DOI 10.1016/S0169-409X(97)00135-X, PII S0169409X9700135X
Bakker, J., Sanders, A., Van Rooijen, N., Effects of liposome-encapsulated drugs on macrophages: Comparative activity of the diamidine 4',6-diamidino-2-phenylindole and the phenanthridinium salts ethidium bromide and propidium iodide (1998) Biochimica et Biophysica Acta - Biomembranes, 1373 (1), pp. 93-100. , DOI 10.1016/S0005-2736(98)00089-3, PII S0005273698000893
Mayer, L.D., Future developments in the selectivity of anticancer agents: Drug delivery and molecular target strategies (1998) Cancer and Metastasis Reviews, 17 (2), pp. 211-218. , DOI 10.1023/A:1006070906949
Sharma, A., Sharma, U.S., Liposomes in drug delivery: Progress and limitations (1997) International Journal of Pharmaceutics, 154 (2), pp. 123-140. , DOI 10.1016/S0378-5173(97)00135-X, PII S037851739700135X
Boswell, G.W., Buell, D., Bekersky, I., Ambisome (liposomal amphotericin B): A comparative review (1998) Journal of Clinical Pharmacology, 38 (7), pp. 583-592
Allen, T.M., Liposomes: Opportunities in drug delivery (1997) Drugs, 54, pp. 8-14
Allen, T.M., Moase, E.H., Therapeutic opportunities for targeted liposomal drug delivery (1996) Advanced Drug Delivery Reviews, 21 (2), pp. 117-133. , DOI 10.1016/S0169-409X(96)00402-4, PII S0169409X96004024
Bally, M.B., Nayar, R., Masin, D., Hope, M.J., Cullis, P.R., Mayer, L.D., Liposomes with entrapped doxorubicin exhibit extended blood residence times (1990) Biochimica et Biophysica Acta - Biomembranes, 1023 (1), pp. 133-139. , DOI 10.1016/0005-2736(90)90018-J
Bandak, S., Ramu, A., Barenholz, Y., Gabizon, A., Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes (1999) Pharmaceutical Research, 16 (6), pp. 841-846. , DOI 10.1023/A:1018869818282
Coukell, A.J., Spencer, C.M., Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-Related Kaposi's sarcoma (1997) Drugs, 53 (3), pp. 520-538
Gabizon, A., Goren, D., Cohen, R., Barenholz, Y., Development of liposomal anthracyclines: From basics to clinical applications (1998) Journal of Controlled Release, 53 (1-3), pp. 275-279. , DOI 10.1016/S0168-3659(97)00261-7, PII S0168365997002617
Batist, G., Ramakrishnan, G., Rao, C.S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Lee, L.W., Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer (2001) Journal of Clinical Oncology, 19 (5), pp. 1444-1454
Shiraga, E., Barichello, J.M., Ishida, T., Kiwada, H., A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model (2008) Int. J. Pharm., 353, pp. 65-73
Soepenberga, O., Sparrebooma, A., De Jongea, J.A., Real-time pharmacokinetics guiding clinical decisions: Phase i study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumors (2004) Eur. J. Cancer, 40, pp. 681-688
Mita, M., Mita, A., Sarantopoulos, J., Phase i study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies (2009) Cancer Chemother. Pharmacol., 64 (2), pp. 287-295
Johnson, E.M., Ojwang, J.O., Szekely, A., Wallace, T.L., Warnock, D.W., Comparison of in vitro antifungal activities of free and liposome- encapsulated nystatin with those of four amphotericin B formulations (1998) Antimicrobial Agents and Chemotherapy, 42 (6), pp. 1412-1416
Oakley, K.L., Moore, C.B., Denning, D.W., Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole (1999) Antimicrobial Agents and Chemotherapy, 43 (5), pp. 1264-1266
Jessup, C., Reyes, G., Fothergill, A., McCarthy, D., Rinaldi, M., Messer, S., Pfaller, M., Ghannoum, M., A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: A multicenter study (2000) Journal of Chemotherapy, 12 (1), pp. 22-29
Gondal, J.A., Swartz, R.P., Rahman, A., Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice (1989) Antimicrobial Agents and Chemotherapy, 33 (9), pp. 1544-1548
Mayer, L.D., Harasym, T.O., Tardi, P.G., Harasym, N.L., Shew, C.R., Johnstone, S.A., Ramsay, E.C., Janoff, A.S., Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice (2006) Molecular Cancer Therapeutics, 5 (7), pp. 1854-1863. , DOI 10.1158/1535-7163.MCT-06-0118
Wang, J., Goh, B., Lu, W., Zhang, Q., Chang, A., Liu, X.Y., Mc Tan, T., Lee, H., In vitro cytotoxicity of stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells (2005) Biological and Pharmaceutical Bulletin, 28 (5), pp. 822-828. , DOI 10.1248/bpb.28.822
Battistini, E., Gianolio, E., Gref, R., High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-b -cyclodextrin (2008) Chem. Eur. J., 14, pp. 4551-4561
Aime, S., Botta, M., Garino, E., Noncovalent conjugates between cationic polyamino acids and GdIII chelates: A route for seeking accumulation of MRI-contrast agents at tumor targeting sites (2000) Chem. Eur. J., 6 (14), pp. 2609-2617
Tilcock, C., Unger, E., Cullis, P., MacDougall, P., Liposomal Gd-DTPA: Preparation and characterization of relaxivity (1989) Radiology, 171 (1), pp. 77-80
Kabalka, G., Buonocore, E., Hubner, K., Gadolinium-labeled liposomes: Targeted MR contrast agents for the liver and spleen (1987) Radiology, 163 (1), pp. 255-258
Grant, C.W.M., Karlik, S., Florio, E., A liposomal MRI contrast agent: Phosphatidylethanolamine-DTPA (1989) Magnetic Resonance in Medicine, 11 (2), pp. 236-243
Unger, E., Fritz, T., Wu, G., Liposomal MR contrast agents (1994) J. Liposome Res., 4 (2), pp. 811-834
Unger, E., Shen, D.K., Wu, G.L., Fritz, T., Liposomes as MR contrast agents: Pros and cons (1991) Magn. Reson. Med., 22 (2), pp. 304-308
Koenig, S.H., Ahkong, Q.F., Brown Iii, R.D., Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions (1992) Magn. Reson. Med., 23 (2), pp. 275-286
Kabalka, G.W., Davis, M.A., Buonocore, E., Hubner, K., Holmberg, E., Huang, L., Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging (1990) Investigative Radiology, 25 (SUPPL. 1), pp. S63-S64
Kabalka, G.W., Buonocore, E., Hubner, K., Davis, M., Huang, L., Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver (1988) Magn. Reson. Med., 8 (1), pp. 89-95
Kim, S.K., Pohost, G.M., Elgavish, G.A., Fatty-acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging (1991) Magn. Reson. Med., 22 (1), pp. 57-67
Marcucci, F., Lefoulon, F., Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress (2004) Drug Discovery Today, 9 (5), pp. 219-228. , DOI 10.1016/S1359-6446(03)02988-X, PII S135964460302988X
Torchilin, V.P., Antibody-modified liposomes for cancer chemotherapy (2008) Expert Opin. Drug Deliv., 5 (9), pp. 1003-1025
Sofou, S., Sgouros, G., Antibody-targeted liposomes in cancer therapy and imaging (2008) Expert Opinion on Drug Delivery, 5 (2), pp. 189-204. , DOI 10.1517/17425247.5.2.189
Wu, H., Chang, D.K., Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy (2010) J. Oncol., , DOI: 10.1155/2010/723798 Epub ahead of print
Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers (2005) Nature Reviews Drug Discovery, 4 (2), pp. 145-160. , DOI 10.1038/nrd1632
Allen, T.M., Ligand-targeted therapeutics in anticancer therapy (2002) Nature Reviews Cancer, 2 (10), pp. 750-763. , DOI 10.1038/nrc903
Van Tilborg, G.A.F., Mulder, W.J.M., Deckers, N., Storm, G., Reutelingsperger, C.P.M., Strijkers, G.J., Nicolay, K., Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis (2006) Bioconjugate Chemistry, 17 (3), pp. 741-749. , DOI 10.1021/bc0600259
Mulder, W.J.M., Strijkers, G.J., Van Tilborg Gaf, Cormode, D.P., Fayad, Z.A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc. Chem. Res., 42 (7), pp. 904-914
Bull, S.R., Guler, M.O., Bras, R.E., Meade, T.J., Stupp, S.I., Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents (2005) Nano Letters, 5 (1), pp. 1-4. , DOI 10.1021/nl0484898
Lipinski, M.J., Amirbekian, V., Frias, J.C., Aguinaldo, J.G.S., Mani, V., Briley-Saebo, K.C., Fuster, V., Fayad, Z.A., MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor (2006) Magnetic Resonance in Medicine, 56 (3), pp. 601-610. , DOI 10.1002/mrm.20995
Amirbekian, V., Lipinski, M.J., Briley-Saebo, K.C., Amirbekian, S., Aguinaldo, J.G.S., Weinreb, D.B., Vucic, E., Fayad, Z.A., Detecting and assessing macrophages in vivo to evalute atherosclerosis noninvasively using molecular MRI (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (3), pp. 961-966. , DOI 10.1073/pnas.0606281104
Li, K.C.P., Bednarski, M.D., Vascular-targeted molecular imaging using functionalized polymerized vesicles (2002) Journal of Magnetic Resonance Imaging, 16 (4), pp. 388-393. , DOI 10.1002/jmri.10174
Storrs, R.W., Tropper, F.D., Li, H.Y., Paramagnetic polymerized liposomes: Synthesis, characterization, and applications for magnetic resonance imaging (1995) J. Am. Chem. Soc., 117 (28), pp. 7301-7306
Sipkins, D.A., Cheresh, D.A., Kazemi, M.R., Nevin, L.M., Bednarski, M.D., Li, K.C.P., Detection of tumor angiogenesis in vivo by α(v)β 3- targeted magnetic resonance imaging (1998) Nature Medicine, 4 (5), pp. 623-626. , DOI 10.1038/nm0598-623
Sipkins, D.A., Gijbels, K., Tropper, F.D., Bednarski, M., Li, K.C.P., Steinman, L., ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging (2000) Journal of Neuroimmunology, 104 (1), pp. 1-9. , DOI 10.1016/S0165-5728(99)00248-9, PII S0165572899002489
Wjm, M., Van Der Schaft Dwj, Pai, H., Early in vivo assessment of angiostatic therapy efficacy by molecular MRI (2007) FASEB J., 21 (2), pp. 378-383
Brandwijk, R.J.M.G.E., Mulder, W.J.M., Nicolay, K., Mayo, K.H., Thijssen, V.L.J.L., Griffioen, A.W., Anginex-conjugated liposomes for targeting of angiogenic endothelial cells (2007) Bioconjugate Chemistry, 18 (3), pp. 785-790. , DOI 10.1021/bc060316h
Kluza, E., Van Der Schaft, D.W., Hautvast, P.A., Synergistic targeting of avb3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis (2010) Nano Lett., 10 (1), pp. 52-58
Ferrari, M., Cancer nanotechnology: Opportunities and challenges (2005) Nature Reviews Cancer, 5 (3), pp. 161-171. , DOI 10.1038/nrc1566
Vaccaro, M., Mangiapia, G., Radulescu, A., Colloidal particles composed of amphiphilic molecules binding gadolinium complexes and peptides as tumor-specific contrast agents in MRI: Physico-chemical characterization (2009) Soft Matter, 5 (13), pp. 2504-2512
Accardo, A., Tesauro, D., Roscigno, P., Gianolio, E., Paduano, L., D'Errico, G., Pedone, C., Morelli, G., Physicochemical Properties of Mixed Micellar Aggregates Containing CCK Peptides and Gd Complexes Designed as Tumor Specific Contrast Agents in MRI (2004) Journal of the American Chemical Society, 126 (10), pp. 3097-3107. , DOI 10.1021/ja039195b
Mangiapia, G., Accardo, A., Lo Celso, F., Mixed micelles composed of peptides and gadolinium complexes as tumor-specific contrast agents in MRI: A SANS study (2004) J. Phys. Chem. B, 108, pp. 17611-17617
Vaccaro, M., Accardo, A., Tesauro, D., Mangiapia, G., Lof, D., Schillen, K., Soderman, O., Paduano, L., Supramolecular aggregates of amphiphilic gadolinium complexes as blood pool MRI/MRA contrast agents: Physicochemical characterization (2006) Langmuir, 22 (15), pp. 6635-6643. , DOI 10.1021/la053500k
Tesauro, D., Accardo, A., Gianolio, E., Paduano, L., Teixeira, J., Schillen, K., Aime, S., Morelli, G., Peptide derivatized lamellar aggregates as target-specific MRI contrast agents (2007) ChemBioChem, 8 (8), pp. 950-955. , DOI 10.1002/cbic.200700077
Morisco, A., Accardo, A., Tesauro, D., Palumbo, R., Benedetti, E., Morelli, G., Peptide labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells (2010) Biopolymers, , DOI: 10.1002/bip.21491 Epub ahead of print
Accardo, A., Mansi, R., Morisco, A., Peptide modified nanocarriers for selective targeting of bombesin receptors (2010) Mol. Biosyst., 6, pp. 878-887
Accardo, A., Morisco, A., Gianolio, E., Octreotide as target-selective delivery tool of nanoparticles for MRI application (2010) J. Pept. Sci., , DOI: 10.1002/psc.1308 Epub ahead of print
Silvente-Poirot, S., Dufresne, M., Vaysse, N., Fourmy, D., The peripheral cholecystokinin receptors (1993) European Journal of Biochemistry, 215 (3), pp. 513-529
Wank, S.A., Cholecystokinin receptors (1995) The American journal of physiology, 269 (51), pp. G628-G646
Reubi, J.C., Schaer, J.-C., Waser, B., Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors (1997) Cancer Research, 57 (7), pp. 1377-1386
Dufresne, M., Seva, C., Fourmy, D., Cholecystokinin and gastrin receptors (2006) Physiological Reviews, 86 (3), pp. 805-847. , http://physrev.physiology.org/cgi/reprint/86/3/805, DOI 10.1152/physrev.00014.2005
Pellegrini, M., Mierke, D.F., Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy (1999) Biochemistry, 38, pp. 14775-14783
Aloj, L., Caraco, C., Panico, M., Zannetti, A., Del Vecchio, S., Tesauro, D., De Luca, S., Salvatore, M., In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-b receptor imaging (2004) Journal of Nuclear Medicine, 45 (3), pp. 485-494. , http://jnm.snmjournals.org/cgi/reprint/45/3/485
Battey, J.F., Way, J.M., Corjay, M.H., Shapira, H., Kusano, K., Harkins, R., Wu, J.M., Feldman, R.I., Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (2), pp. 395-399
Fathi, Z., Corjay, M.H., Shapira, H., Wada, E., Benya, R., Jensen, R., Viallet, J., Battey, J.F., BRS-3: A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells (1993) Journal of Biological Chemistry, 268 (8), pp. 5979-5984
Nagalla, S.R., Barry, B.J., Creswick, K.C., Eden, P., Taylor, J.T., Cloning of a receptor for amphibian [Phe-13]bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4) (1995) Proc. Natl Acad. Sci. USA, 92 (13), pp. 6205-6209
Wada, E., Way, J., Shapira, H., CDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor (1991) Neuron, 6 (3), pp. 421-430
Markwalder, R., Reubi, J.C., Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation (1999) Cancer Research, 59 (5), pp. 1152-1159
Gugger, M., Reubi, J.C., Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast (1999) Am. J. Pathol., 155 (6), pp. 2067-2076
Fleischmann, A., Waser, B., Reubi, J.C., Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms (2007) Cellular Oncology, 29 (5), pp. 421-433
Smith, C.J., Volkert, W.A., Hoffman, T.J., Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes (2005) Nuclear Medicine and Biology, 32 (7), pp. 733-740. , DOI 10.1016/j.nucmedbio.2005.05.005, PII S0969805105001423
Lamberts, S.W.J., Somatostatin analogues from one decade to the second (1999) Octreotide: The Next Decade, , Lamberts SWJ (Ed.) Bristol Bioscientifica, UK 3-65
Bauer, W., Briner, U., Doepfner, W., SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action (1982) Life Sciences, 31 (11), pp. 1133-1140. , DOI 10.1016/0024-3205(82)90087-X
Veber, D.F., Freidinger, R.M., Perlow, D.S., A potent cyclic hexapeptide analogue of somatostatin (1981) Nature, 292 (5818), pp. 55-58. , DOI 10.1038/292055a0
Kowalski, J., Henze, M., Schuhmacher, J., Macke, H.R., Hofmann, M., Haberkorn, U., Evaluation of positron emission tomography imaging using [ 68 Ga]-DOTA-D Phe 1-Tyr 3- octreotidein comparison to [ 111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors (2003) Molecular Imaging and Biology, 5 (1), pp. 42-48. , DOI 10.1016/S1536-1632(03)00038-6, PII S1536163203000386
Reubi, J.C., Waser, B., Schaer, J.C., Laissue, J.A., Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur. J. Nucl. Med., 28, pp. 836-846. , Erratum in: Eur. J. Nucl. Med. 28, 1433 (2001)
Bell, G., Reisine, T., Molecular biology of somatostatin receptors (1993) Trends Neurosci., 16, pp. 34-38
Reubi, J.C., Horisberger, U., Laissue, J., High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? (1994) International Journal of Cancer, 56 (5), pp. 681-688
Reubi, J.C., Peptide receptors as molecular targets for cancer diagnosis and therapy (2003) Endocrine Reviews, 24 (4), pp. 389-427. , DOI 10.1210/er.2002-0007
Anelli, P.L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents (2001) Magnetic Resonance Materials in Physics, Biology and Medicine, 12 (2-3), pp. 114-120. , DOI 10.1016/S1352-8661(01)00107-7, PII S1352866101001077
Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., Metal containing nanosized systems for MR-molecular imaging applications (2008) Coord. Chem. Rev., 252 (21-22), pp. 2424-2443
Menger, F.M., Littau, C.A., Gemini-surfactants: Synthesis and properties (1991) J. Am. Chem. Soc., 113, pp. 1451-1452
Zana, R., Dimeric and oligomeric surfactants. Behavior at interfaces and in aqueous solution: A review (2002) Advances in Colloid and Interface Science, 97 (1-3), pp. 205-253. , PII S0001868601000690
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., O'Brien, D. F., Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes (1998) Biochemistry, 37 (37), pp. 12875-12883. , DOI 10. 1021/bi980096y
Scherphof, G. L., Kamps, J. A. A. M., Receptor versus non-receptor mediated clearance of liposomes (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 81-97. , DOI 10. 1016/S0169-409X (97) 00133-6, PII S0169409X97001336
Papisov, M. I., Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 119-138. , DOI 10. 1016/S0169-409X (97) 00135-X, PII S0169409X9700135X
Mayer, L. D., Future developments in the selectivity of anticancer agents: Drug delivery and molecular target strategies (1998) Cancer and Metastasis Reviews, 17 (2), pp. 211-218. , DOI 10. 1023/A: 1006070906949
Boswell, G. W., Buell, D., Bekersky, I., Ambisome (liposomal amphotericin B): A comparative review (1998) Journal of Clinical Pharmacology, 38 (7), pp. 583-592
Allen, T. M., Liposomes: Opportunities in drug delivery (1997) Drugs, 54, pp. 8-14
Allen, T. M., Moase, E. H., Therapeutic opportunities for targeted liposomal drug delivery (1996) Advanced Drug Delivery Reviews, 21 (2), pp. 117-133. , DOI 10. 1016/S0169-409X (96) 00402-4, PII S0169409X96004024
Bally, M. B., Nayar, R., Masin, D., Hope, M. J., Cullis, P. R., Mayer, L. D., Liposomes with entrapped doxorubicin exhibit extended blood residence times (1990) Biochimica et Biophysica Acta - Biomembranes, 1023 (1), pp. 133-139. , DOI 10. 1016/0005-2736 (90) 90018-J
Coukell, A. J., Spencer, C. M., Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-Related Kaposi's sarcoma (1997) Drugs, 53 (3), pp. 520-538
Johnson, E. M., Ojwang, J. O., Szekely, A., Wallace, T. L., Warnock, D. W., Comparison of in vitro antifungal activities of free and liposome- encapsulated nystatin with those of four amphotericin B formulations (1998) Antimicrobial Agents and Chemotherapy, 42 (6), pp. 1412-1416
Oakley, K. L., Moore, C. B., Denning, D. W., Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole (1999) Antimicrobial Agents and Chemotherapy, 43 (5), pp. 1264-1266
Gondal, J. A., Swartz, R. P., Rahman, A., Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice (1989) Antimicrobial Agents and Chemotherapy, 33 (9), pp. 1544-1548
Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Janoff, A. S., Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice (2006) Molecular Cancer Therapeutics, 5 (7), pp. 1854-1863. , DOI 10. 1158/1535-7163. MCT-06-0118
Grant, C. W. M., Karlik, S., Florio, E., A liposomal MRI contrast agent: Phosphatidylethanolamine-DTPA (1989) Magnetic Resonance in Medicine, 11 (2), pp. 236-243
Koenig, S. H., Ahkong, Q. F., Brown Iii, R. D., Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions (1992) Magn. Reson. Med., 23 (2), pp. 275-286
Kabalka, G. W., Davis, M. A., Buonocore, E., Hubner, K., Holmberg, E., Huang, L., Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging (1990) Investigative Radiology, 25 (SUPPL. 1), pp. S63-S64
Kabalka, G. W., Buonocore, E., Hubner, K., Davis, M., Huang, L., Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver (1988) Magn. Reson. Med., 8 (1), pp. 89-95
Kim, S. K., Pohost, G. M., Elgavish, G. A., Fatty-acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging (1991) Magn. Reson. Med., 22 (1), pp. 57-67
Torchilin, V. P., Antibody-modified liposomes for cancer chemotherapy (2008) Expert Opin. Drug Deliv., 5 (9), pp. 1003-1025
Wu, H., Chang, D. K., Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy (2010) J. Oncol., , DOI: 10. 1155/2010/723798 Epub ahead of print
Torchilin, V. P., Recent advances with liposomes as pharmaceutical carriers (2005) Nature Reviews Drug Discovery, 4 (2), pp. 145-160. , DOI 10. 1038/nrd1632
Allen, T. M., Ligand-targeted therapeutics in anticancer therapy (2002) Nature Reviews Cancer, 2 (10), pp. 750-763. , DOI 10. 1038/nrc903
Van Tilborg, G. A. F., Mulder, W. J. M., Deckers, N., Storm, G., Reutelingsperger, C. P. M., Strijkers, G. J., Nicolay, K., Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis (2006) Bioconjugate Chemistry, 17 (3), pp. 741-749. , DOI 10. 1021/bc0600259
Mulder, W. J. M., Strijkers, G. J., Van Tilborg Gaf, Cormode, D. P., Fayad, Z. A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc. Chem. Res., 42 (7), pp. 904-914
Bull, S. R., Guler, M. O., Bras, R. E., Meade, T. J., Stupp, S. I., Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents (2005) Nano Letters, 5 (1), pp. 1-4. , DOI 10. 1021/nl0484898
Lipinski, M. J., Amirbekian, V., Frias, J. C., Aguinaldo, J. G. S., Mani, V., Briley-Saebo, K. C., Fuster, V., Fayad, Z. A., MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor (2006) Magnetic Resonance in Medicine, 56 (3), pp. 601-610. , DOI 10. 1002/mrm. 20995
Li, K. C. P., Bednarski, M. D., Vascular-targeted molecular imaging using functionalized polymerized vesicles (2002) Journal of Magnetic Resonance Imaging, 16 (4), pp. 388-393. , DOI 10. 1002/jmri. 10174
Storrs, R. W., Tropper, F. D., Li, H. Y., Paramagnetic polymerized liposomes: Synthesis, characterization, and applications for magnetic resonance imaging (1995) J. Am. Chem. Soc., 117 (28), pp. 7301-7306
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., Li, K. C. P., Detection of tumor angiogenesis in vivo by (v) 3- targeted magnetic resonance imaging (1998) Nature Medicine, 4 (5), pp. 623-626. , DOI 10. 1038/nm0598-623
Sipkins, D. A., Gijbels, K., Tropper, F. D., Bednarski, M., Li, K. C. P., Steinman, L., ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging (2000) Journal of Neuroimmunology, 104 (1), pp. 1-9. , DOI 10. 1016/S0165-5728 (99) 00248-9, PII S0165572899002489
Brandwijk, R. J. M. G. E., Mulder, W. J. M., Nicolay, K., Mayo, K. H., Thijssen, V. L. J. L., Griffioen, A. W., Anginex-conjugated liposomes for targeting of angiogenic endothelial cells (2007) Bioconjugate Chemistry, 18 (3), pp. 785-790. , DOI 10. 1021/bc060316h
Wank, S. A., Cholecystokinin receptors (1995) The American journal of physiology, 269 (51), pp. G628-G646
Reubi, J. C., Schaer, J. -C., Waser, B., Cholecystokinin (CCK) -A and CCK-B/gastrin receptors in human tumors (1997) Cancer Research, 57 (7), pp. 1377-1386
Battey, J. F., Way, J. M., Corjay, M. H., Shapira, H., Kusano, K., Harkins, R., Wu, J. M., Feldman, R. I., Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (2), pp. 395-399
Nagalla, S. R., Barry, B. J., Creswick, K. C., Eden, P., Taylor, J. T., Cloning of a receptor for amphibian [Phe-13] bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4) (1995) Proc. Natl Acad. Sci. USA, 92 (13), pp. 6205-6209
Smith, C. J., Volkert, W. A., Hoffman, T. J., Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes (2005) Nuclear Medicine and Biology, 32 (7), pp. 733-740. , DOI 10. 1016/j. nucmedbio. 2005. 05. 005, PII S0969805105001423
Lamberts, S. W. J., Somatostatin analogues from one decade to the second (1999) Octreotide: The Next Decade, , Lamberts SWJ (Ed.) Bristol Bioscientifica, UK 3-65
Veber, D. F., Freidinger, R. M., Perlow, D. S., A potent cyclic hexapeptide analogue of somatostatin (1981) Nature, 292 (5818), pp. 55-58. , DOI 10. 1038/292055a0
Reubi, J. C., Waser, B., Schaer, J. C., Laissue, J. A., Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur. J. Nucl. Med., 28, pp. 836-846. , Erratum in: Eur. J. Nucl. Med. 28, 1433 (2001)
Reubi, J. C., Horisberger, U., Laissue, J., High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? (1994) International Journal of Cancer, 56 (5), pp. 681-688
Reubi, J. C., Peptide receptors as molecular targets for cancer diagnosis and therapy (2003) Endocrine Reviews, 24 (4), pp. 389-427. , DOI 10. 1210/er. 2002-0007
Anelli, P. L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents (2001) Magnetic Resonance Materials in Physics, Biology and Medicine, 12 (2-3), pp. 114-120. , DOI 10. 1016/S1352-8661 (01) 00107-7, PII S1352866101001077
Menger, F. M., Littau, C. A., Gemini-surfactants: Synthesis and properties (1991) J. Am. Chem. Soc., 113, pp. 1451-1452
Ther Deliv (ISSN: 2041-5990), 2011 Feb; 2(2): 235-257.
Export to BibTeX Export to EndNote
Paper type: Journal Article, Review,
Impact factor: 0, 5-year impact factor: 0
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-79954479044&partnerID=40&md5=736a90e7eed662b18b9d9e9a0e8e3f83
Keywords: 7-14 Bombesin, Amphotericin B, Amphotericin B Lipid Complex, Chelating Agent, Cholecystokinin A Receptor, Cholecystokinin B Receptor, Cholecystokinin Octapeptide, Cyclophosphamide, Daunorubicin, Docetaxel, Doxorubicin, Gadolinium Diethylenetriamine Pentaacetic Acid, Gadolinium Pentetate, Gadoteridol, Liposome, Monomer, Nanoparticle, Naposome, Nuclear Magnetic Resonance Imaging Agent, Octroscan, Paclitaxel, Pentetreotide In 111, Peptide Derivative, Polysorbate 80, Unclassified Drug, Vincristine, Breast Cancer, Cardiotoxicity, Cell Proliferation, Drug Determination, Drug Dosage Form Comparison, Drug Efficacy, Drug Formulation, Drug Receptor Binding, Drug Safety, Encapsulation, Flow Cytometry, Gastrointestinal Symptom, Human, Hydrophobicity, Lung Metastasis, Lymphoma, Melanoma, Micelle, Molecular Weight, Nervous System Tumor, Neuroendocrine Tumor, Nonhuman, Particle Size, Priority Journal, Contrast Media, Drug Delivery Systems,
Affiliations:
*** IBB - CNR ***
Department of Biological Sciences and CIRPeB, University of Naples Federico II, Via Mezzocannone 16, 80134 Naples, Italy
References:
Gregoriadis, G., Ryman, B.E., Lysosomal localization of fructofuranoside-containing liposomes injected into rats (1972) Biochem. J., 129, pp. 123-13
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review (2000) Journal of Controlled Release, 65 (1-2), pp. 271-284. , DOI 10.1016/S0168-3659(99)00248-5, PII S0168365999002485
Bajoria, R., Contractor, S.F., Effect of surface charge of small unilamellar liposomes on uptake and transfer of carboxyfluorescein across the perfused human term placenta (1997) Pediatric Research, 42 (4), pp. 520-527
Miller, C.R., Bondurant, B., McLean, S.D., McGovern, K.A., O'Brien, D.F., Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes (1998) Biochemistry, 37 (37), pp. 12875-12883. , DOI 10.1021/bi980096y
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., Fujiwara, H., Mayumi, T., Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins (1997) Biochemical and Biophysical Research Communications, 240 (3), pp. 793-797. , DOI 10.1006/bbrc.1997.7749
Scherphof, G.L., Kamps, J.A.A.M., Receptor versus non-receptor mediated clearance of liposomes (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 81-97. , DOI 10.1016/S0169-409X(97)00133-6, PII S0169409X97001336
Papisov, M.I., Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 119-138. , DOI 10.1016/S0169-409X(97)00135-X, PII S0169409X9700135X
Bakker, J., Sanders, A., Van Rooijen, N., Effects of liposome-encapsulated drugs on macrophages: Comparative activity of the diamidine 4',6-diamidino-2-phenylindole and the phenanthridinium salts ethidium bromide and propidium iodide (1998) Biochimica et Biophysica Acta - Biomembranes, 1373 (1), pp. 93-100. , DOI 10.1016/S0005-2736(98)00089-3, PII S0005273698000893
Mayer, L.D., Future developments in the selectivity of anticancer agents: Drug delivery and molecular target strategies (1998) Cancer and Metastasis Reviews, 17 (2), pp. 211-218. , DOI 10.1023/A:1006070906949
Sharma, A., Sharma, U.S., Liposomes in drug delivery: Progress and limitations (1997) International Journal of Pharmaceutics, 154 (2), pp. 123-140. , DOI 10.1016/S0378-5173(97)00135-X, PII S037851739700135X
Boswell, G.W., Buell, D., Bekersky, I., Ambisome (liposomal amphotericin B): A comparative review (1998) Journal of Clinical Pharmacology, 38 (7), pp. 583-592
Allen, T.M., Liposomes: Opportunities in drug delivery (1997) Drugs, 54, pp. 8-14
Allen, T.M., Moase, E.H., Therapeutic opportunities for targeted liposomal drug delivery (1996) Advanced Drug Delivery Reviews, 21 (2), pp. 117-133. , DOI 10.1016/S0169-409X(96)00402-4, PII S0169409X96004024
Bally, M.B., Nayar, R., Masin, D., Hope, M.J., Cullis, P.R., Mayer, L.D., Liposomes with entrapped doxorubicin exhibit extended blood residence times (1990) Biochimica et Biophysica Acta - Biomembranes, 1023 (1), pp. 133-139. , DOI 10.1016/0005-2736(90)90018-J
Bandak, S., Ramu, A., Barenholz, Y., Gabizon, A., Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes (1999) Pharmaceutical Research, 16 (6), pp. 841-846. , DOI 10.1023/A:1018869818282
Coukell, A.J., Spencer, C.M., Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-Related Kaposi's sarcoma (1997) Drugs, 53 (3), pp. 520-538
Gabizon, A., Goren, D., Cohen, R., Barenholz, Y., Development of liposomal anthracyclines: From basics to clinical applications (1998) Journal of Controlled Release, 53 (1-3), pp. 275-279. , DOI 10.1016/S0168-3659(97)00261-7, PII S0168365997002617
Batist, G., Ramakrishnan, G., Rao, C.S., Chandrasekharan, A., Gutheil, J., Guthrie, T., Shah, P., Lee, L.W., Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer (2001) Journal of Clinical Oncology, 19 (5), pp. 1444-1454
Shiraga, E., Barichello, J.M., Ishida, T., Kiwada, H., A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model (2008) Int. J. Pharm., 353, pp. 65-73
Soepenberga, O., Sparrebooma, A., De Jongea, J.A., Real-time pharmacokinetics guiding clinical decisions: Phase i study of a weekly schedule of liposome encapsulated paclitaxel in patients with solid tumors (2004) Eur. J. Cancer, 40, pp. 681-688
Mita, M., Mita, A., Sarantopoulos, J., Phase i study of paclitaxel poliglumex administered weekly for patients with advanced solid malignancies (2009) Cancer Chemother. Pharmacol., 64 (2), pp. 287-295
Johnson, E.M., Ojwang, J.O., Szekely, A., Wallace, T.L., Warnock, D.W., Comparison of in vitro antifungal activities of free and liposome- encapsulated nystatin with those of four amphotericin B formulations (1998) Antimicrobial Agents and Chemotherapy, 42 (6), pp. 1412-1416
Oakley, K.L., Moore, C.B., Denning, D.W., Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole (1999) Antimicrobial Agents and Chemotherapy, 43 (5), pp. 1264-1266
Jessup, C., Reyes, G., Fothergill, A., McCarthy, D., Rinaldi, M., Messer, S., Pfaller, M., Ghannoum, M., A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: A multicenter study (2000) Journal of Chemotherapy, 12 (1), pp. 22-29
Gondal, J.A., Swartz, R.P., Rahman, A., Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice (1989) Antimicrobial Agents and Chemotherapy, 33 (9), pp. 1544-1548
Mayer, L.D., Harasym, T.O., Tardi, P.G., Harasym, N.L., Shew, C.R., Johnstone, S.A., Ramsay, E.C., Janoff, A.S., Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice (2006) Molecular Cancer Therapeutics, 5 (7), pp. 1854-1863. , DOI 10.1158/1535-7163.MCT-06-0118
Wang, J., Goh, B., Lu, W., Zhang, Q., Chang, A., Liu, X.Y., Mc Tan, T., Lee, H., In vitro cytotoxicity of stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells (2005) Biological and Pharmaceutical Bulletin, 28 (5), pp. 822-828. , DOI 10.1248/bpb.28.822
Battistini, E., Gianolio, E., Gref, R., High-relaxivity magnetic resonance imaging (MRI) contrast agent based on supramolecular assembly between a gadolinium chelate, a modified dextran, and poly-b -cyclodextrin (2008) Chem. Eur. J., 14, pp. 4551-4561
Aime, S., Botta, M., Garino, E., Noncovalent conjugates between cationic polyamino acids and GdIII chelates: A route for seeking accumulation of MRI-contrast agents at tumor targeting sites (2000) Chem. Eur. J., 6 (14), pp. 2609-2617
Tilcock, C., Unger, E., Cullis, P., MacDougall, P., Liposomal Gd-DTPA: Preparation and characterization of relaxivity (1989) Radiology, 171 (1), pp. 77-80
Kabalka, G., Buonocore, E., Hubner, K., Gadolinium-labeled liposomes: Targeted MR contrast agents for the liver and spleen (1987) Radiology, 163 (1), pp. 255-258
Grant, C.W.M., Karlik, S., Florio, E., A liposomal MRI contrast agent: Phosphatidylethanolamine-DTPA (1989) Magnetic Resonance in Medicine, 11 (2), pp. 236-243
Unger, E., Fritz, T., Wu, G., Liposomal MR contrast agents (1994) J. Liposome Res., 4 (2), pp. 811-834
Unger, E., Shen, D.K., Wu, G.L., Fritz, T., Liposomes as MR contrast agents: Pros and cons (1991) Magn. Reson. Med., 22 (2), pp. 304-308
Koenig, S.H., Ahkong, Q.F., Brown Iii, R.D., Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions (1992) Magn. Reson. Med., 23 (2), pp. 275-286
Kabalka, G.W., Davis, M.A., Buonocore, E., Hubner, K., Holmberg, E., Huang, L., Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging (1990) Investigative Radiology, 25 (SUPPL. 1), pp. S63-S64
Kabalka, G.W., Buonocore, E., Hubner, K., Davis, M., Huang, L., Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver (1988) Magn. Reson. Med., 8 (1), pp. 89-95
Kim, S.K., Pohost, G.M., Elgavish, G.A., Fatty-acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging (1991) Magn. Reson. Med., 22 (1), pp. 57-67
Marcucci, F., Lefoulon, F., Active targeting with particulate drug carriers in tumor therapy: Fundamentals and recent progress (2004) Drug Discovery Today, 9 (5), pp. 219-228. , DOI 10.1016/S1359-6446(03)02988-X, PII S135964460302988X
Torchilin, V.P., Antibody-modified liposomes for cancer chemotherapy (2008) Expert Opin. Drug Deliv., 5 (9), pp. 1003-1025
Sofou, S., Sgouros, G., Antibody-targeted liposomes in cancer therapy and imaging (2008) Expert Opinion on Drug Delivery, 5 (2), pp. 189-204. , DOI 10.1517/17425247.5.2.189
Wu, H., Chang, D.K., Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy (2010) J. Oncol., , DOI: 10.1155/2010/723798 Epub ahead of print
Torchilin, V.P., Recent advances with liposomes as pharmaceutical carriers (2005) Nature Reviews Drug Discovery, 4 (2), pp. 145-160. , DOI 10.1038/nrd1632
Allen, T.M., Ligand-targeted therapeutics in anticancer therapy (2002) Nature Reviews Cancer, 2 (10), pp. 750-763. , DOI 10.1038/nrc903
Van Tilborg, G.A.F., Mulder, W.J.M., Deckers, N., Storm, G., Reutelingsperger, C.P.M., Strijkers, G.J., Nicolay, K., Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis (2006) Bioconjugate Chemistry, 17 (3), pp. 741-749. , DOI 10.1021/bc0600259
Mulder, W.J.M., Strijkers, G.J., Van Tilborg Gaf, Cormode, D.P., Fayad, Z.A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc. Chem. Res., 42 (7), pp. 904-914
Bull, S.R., Guler, M.O., Bras, R.E., Meade, T.J., Stupp, S.I., Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents (2005) Nano Letters, 5 (1), pp. 1-4. , DOI 10.1021/nl0484898
Lipinski, M.J., Amirbekian, V., Frias, J.C., Aguinaldo, J.G.S., Mani, V., Briley-Saebo, K.C., Fuster, V., Fayad, Z.A., MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor (2006) Magnetic Resonance in Medicine, 56 (3), pp. 601-610. , DOI 10.1002/mrm.20995
Amirbekian, V., Lipinski, M.J., Briley-Saebo, K.C., Amirbekian, S., Aguinaldo, J.G.S., Weinreb, D.B., Vucic, E., Fayad, Z.A., Detecting and assessing macrophages in vivo to evalute atherosclerosis noninvasively using molecular MRI (2007) Proceedings of the National Academy of Sciences of the United States of America, 104 (3), pp. 961-966. , DOI 10.1073/pnas.0606281104
Li, K.C.P., Bednarski, M.D., Vascular-targeted molecular imaging using functionalized polymerized vesicles (2002) Journal of Magnetic Resonance Imaging, 16 (4), pp. 388-393. , DOI 10.1002/jmri.10174
Storrs, R.W., Tropper, F.D., Li, H.Y., Paramagnetic polymerized liposomes: Synthesis, characterization, and applications for magnetic resonance imaging (1995) J. Am. Chem. Soc., 117 (28), pp. 7301-7306
Sipkins, D.A., Cheresh, D.A., Kazemi, M.R., Nevin, L.M., Bednarski, M.D., Li, K.C.P., Detection of tumor angiogenesis in vivo by α(v)β 3- targeted magnetic resonance imaging (1998) Nature Medicine, 4 (5), pp. 623-626. , DOI 10.1038/nm0598-623
Sipkins, D.A., Gijbels, K., Tropper, F.D., Bednarski, M., Li, K.C.P., Steinman, L., ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging (2000) Journal of Neuroimmunology, 104 (1), pp. 1-9. , DOI 10.1016/S0165-5728(99)00248-9, PII S0165572899002489
Wjm, M., Van Der Schaft Dwj, Pai, H., Early in vivo assessment of angiostatic therapy efficacy by molecular MRI (2007) FASEB J., 21 (2), pp. 378-383
Brandwijk, R.J.M.G.E., Mulder, W.J.M., Nicolay, K., Mayo, K.H., Thijssen, V.L.J.L., Griffioen, A.W., Anginex-conjugated liposomes for targeting of angiogenic endothelial cells (2007) Bioconjugate Chemistry, 18 (3), pp. 785-790. , DOI 10.1021/bc060316h
Kluza, E., Van Der Schaft, D.W., Hautvast, P.A., Synergistic targeting of avb3 integrin and galectin-1 with heteromultivalent paramagnetic liposomes for combined MR imaging and treatment of angiogenesis (2010) Nano Lett., 10 (1), pp. 52-58
Ferrari, M., Cancer nanotechnology: Opportunities and challenges (2005) Nature Reviews Cancer, 5 (3), pp. 161-171. , DOI 10.1038/nrc1566
Vaccaro, M., Mangiapia, G., Radulescu, A., Colloidal particles composed of amphiphilic molecules binding gadolinium complexes and peptides as tumor-specific contrast agents in MRI: Physico-chemical characterization (2009) Soft Matter, 5 (13), pp. 2504-2512
Accardo, A., Tesauro, D., Roscigno, P., Gianolio, E., Paduano, L., D'Errico, G., Pedone, C., Morelli, G., Physicochemical Properties of Mixed Micellar Aggregates Containing CCK Peptides and Gd Complexes Designed as Tumor Specific Contrast Agents in MRI (2004) Journal of the American Chemical Society, 126 (10), pp. 3097-3107. , DOI 10.1021/ja039195b
Mangiapia, G., Accardo, A., Lo Celso, F., Mixed micelles composed of peptides and gadolinium complexes as tumor-specific contrast agents in MRI: A SANS study (2004) J. Phys. Chem. B, 108, pp. 17611-17617
Vaccaro, M., Accardo, A., Tesauro, D., Mangiapia, G., Lof, D., Schillen, K., Soderman, O., Paduano, L., Supramolecular aggregates of amphiphilic gadolinium complexes as blood pool MRI/MRA contrast agents: Physicochemical characterization (2006) Langmuir, 22 (15), pp. 6635-6643. , DOI 10.1021/la053500k
Tesauro, D., Accardo, A., Gianolio, E., Paduano, L., Teixeira, J., Schillen, K., Aime, S., Morelli, G., Peptide derivatized lamellar aggregates as target-specific MRI contrast agents (2007) ChemBioChem, 8 (8), pp. 950-955. , DOI 10.1002/cbic.200700077
Morisco, A., Accardo, A., Tesauro, D., Palumbo, R., Benedetti, E., Morelli, G., Peptide labeled supramolecular aggregates as selective doxorubicin carriers for delivery to tumor cells (2010) Biopolymers, , DOI: 10.1002/bip.21491 Epub ahead of print
Accardo, A., Mansi, R., Morisco, A., Peptide modified nanocarriers for selective targeting of bombesin receptors (2010) Mol. Biosyst., 6, pp. 878-887
Accardo, A., Morisco, A., Gianolio, E., Octreotide as target-selective delivery tool of nanoparticles for MRI application (2010) J. Pept. Sci., , DOI: 10.1002/psc.1308 Epub ahead of print
Silvente-Poirot, S., Dufresne, M., Vaysse, N., Fourmy, D., The peripheral cholecystokinin receptors (1993) European Journal of Biochemistry, 215 (3), pp. 513-529
Wank, S.A., Cholecystokinin receptors (1995) The American journal of physiology, 269 (51), pp. G628-G646
Reubi, J.C., Schaer, J.-C., Waser, B., Cholecystokinin (CCK)-A and CCK-B/gastrin receptors in human tumors (1997) Cancer Research, 57 (7), pp. 1377-1386
Dufresne, M., Seva, C., Fourmy, D., Cholecystokinin and gastrin receptors (2006) Physiological Reviews, 86 (3), pp. 805-847. , http://physrev.physiology.org/cgi/reprint/86/3/805, DOI 10.1152/physrev.00014.2005
Pellegrini, M., Mierke, D.F., Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy (1999) Biochemistry, 38, pp. 14775-14783
Aloj, L., Caraco, C., Panico, M., Zannetti, A., Del Vecchio, S., Tesauro, D., De Luca, S., Salvatore, M., In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-b receptor imaging (2004) Journal of Nuclear Medicine, 45 (3), pp. 485-494. , http://jnm.snmjournals.org/cgi/reprint/45/3/485
Battey, J.F., Way, J.M., Corjay, M.H., Shapira, H., Kusano, K., Harkins, R., Wu, J.M., Feldman, R.I., Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (2), pp. 395-399
Fathi, Z., Corjay, M.H., Shapira, H., Wada, E., Benya, R., Jensen, R., Viallet, J., Battey, J.F., BRS-3: A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells (1993) Journal of Biological Chemistry, 268 (8), pp. 5979-5984
Nagalla, S.R., Barry, B.J., Creswick, K.C., Eden, P., Taylor, J.T., Cloning of a receptor for amphibian [Phe-13]bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4) (1995) Proc. Natl Acad. Sci. USA, 92 (13), pp. 6205-6209
Wada, E., Way, J., Shapira, H., CDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor (1991) Neuron, 6 (3), pp. 421-430
Markwalder, R., Reubi, J.C., Gastrin-releasing peptide receptors in the human prostate: Relation to neoplastic transformation (1999) Cancer Research, 59 (5), pp. 1152-1159
Gugger, M., Reubi, J.C., Gastrin-releasing peptide receptors in non-neoplastic and neoplastic human breast (1999) Am. J. Pathol., 155 (6), pp. 2067-2076
Fleischmann, A., Waser, B., Reubi, J.C., Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms (2007) Cellular Oncology, 29 (5), pp. 421-433
Smith, C.J., Volkert, W.A., Hoffman, T.J., Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes (2005) Nuclear Medicine and Biology, 32 (7), pp. 733-740. , DOI 10.1016/j.nucmedbio.2005.05.005, PII S0969805105001423
Lamberts, S.W.J., Somatostatin analogues from one decade to the second (1999) Octreotide: The Next Decade, , Lamberts SWJ (Ed.) Bristol Bioscientifica, UK 3-65
Bauer, W., Briner, U., Doepfner, W., SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action (1982) Life Sciences, 31 (11), pp. 1133-1140. , DOI 10.1016/0024-3205(82)90087-X
Veber, D.F., Freidinger, R.M., Perlow, D.S., A potent cyclic hexapeptide analogue of somatostatin (1981) Nature, 292 (5818), pp. 55-58. , DOI 10.1038/292055a0
Kowalski, J., Henze, M., Schuhmacher, J., Macke, H.R., Hofmann, M., Haberkorn, U., Evaluation of positron emission tomography imaging using [ 68 Ga]-DOTA-D Phe 1-Tyr 3- octreotidein comparison to [ 111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors (2003) Molecular Imaging and Biology, 5 (1), pp. 42-48. , DOI 10.1016/S1536-1632(03)00038-6, PII S1536163203000386
Reubi, J.C., Waser, B., Schaer, J.C., Laissue, J.A., Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur. J. Nucl. Med., 28, pp. 836-846. , Erratum in: Eur. J. Nucl. Med. 28, 1433 (2001)
Bell, G., Reisine, T., Molecular biology of somatostatin receptors (1993) Trends Neurosci., 16, pp. 34-38
Reubi, J.C., Horisberger, U., Laissue, J., High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? (1994) International Journal of Cancer, 56 (5), pp. 681-688
Reubi, J.C., Peptide receptors as molecular targets for cancer diagnosis and therapy (2003) Endocrine Reviews, 24 (4), pp. 389-427. , DOI 10.1210/er.2002-0007
Anelli, P.L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents (2001) Magnetic Resonance Materials in Physics, Biology and Medicine, 12 (2-3), pp. 114-120. , DOI 10.1016/S1352-8661(01)00107-7, PII S1352866101001077
Delli Castelli, D., Gianolio, E., Geninatti Crich, S., Terreno, E., Aime, S., Metal containing nanosized systems for MR-molecular imaging applications (2008) Coord. Chem. Rev., 252 (21-22), pp. 2424-2443
Menger, F.M., Littau, C.A., Gemini-surfactants: Synthesis and properties (1991) J. Am. Chem. Soc., 113, pp. 1451-1452
Zana, R., Dimeric and oligomeric surfactants. Behavior at interfaces and in aqueous solution: A review (2002) Advances in Colloid and Interface Science, 97 (1-3), pp. 205-253. , PII S0001868601000690
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., O'Brien, D. F., Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes (1998) Biochemistry, 37 (37), pp. 12875-12883. , DOI 10. 1021/bi980096y
Scherphof, G. L., Kamps, J. A. A. M., Receptor versus non-receptor mediated clearance of liposomes (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 81-97. , DOI 10. 1016/S0169-409X (97) 00133-6, PII S0169409X97001336
Papisov, M. I., Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions (1998) Advanced Drug Delivery Reviews, 32 (1-2), pp. 119-138. , DOI 10. 1016/S0169-409X (97) 00135-X, PII S0169409X9700135X
Mayer, L. D., Future developments in the selectivity of anticancer agents: Drug delivery and molecular target strategies (1998) Cancer and Metastasis Reviews, 17 (2), pp. 211-218. , DOI 10. 1023/A: 1006070906949
Boswell, G. W., Buell, D., Bekersky, I., Ambisome (liposomal amphotericin B): A comparative review (1998) Journal of Clinical Pharmacology, 38 (7), pp. 583-592
Allen, T. M., Liposomes: Opportunities in drug delivery (1997) Drugs, 54, pp. 8-14
Allen, T. M., Moase, E. H., Therapeutic opportunities for targeted liposomal drug delivery (1996) Advanced Drug Delivery Reviews, 21 (2), pp. 117-133. , DOI 10. 1016/S0169-409X (96) 00402-4, PII S0169409X96004024
Bally, M. B., Nayar, R., Masin, D., Hope, M. J., Cullis, P. R., Mayer, L. D., Liposomes with entrapped doxorubicin exhibit extended blood residence times (1990) Biochimica et Biophysica Acta - Biomembranes, 1023 (1), pp. 133-139. , DOI 10. 1016/0005-2736 (90) 90018-J
Coukell, A. J., Spencer, C. M., Polyethylene glycol-liposomal doxorubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the management of AIDS-Related Kaposi's sarcoma (1997) Drugs, 53 (3), pp. 520-538
Johnson, E. M., Ojwang, J. O., Szekely, A., Wallace, T. L., Warnock, D. W., Comparison of in vitro antifungal activities of free and liposome- encapsulated nystatin with those of four amphotericin B formulations (1998) Antimicrobial Agents and Chemotherapy, 42 (6), pp. 1412-1416
Oakley, K. L., Moore, C. B., Denning, D. W., Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole (1999) Antimicrobial Agents and Chemotherapy, 43 (5), pp. 1264-1266
Gondal, J. A., Swartz, R. P., Rahman, A., Therapeutic evaluation of free and liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice (1989) Antimicrobial Agents and Chemotherapy, 33 (9), pp. 1544-1548
Mayer, L. D., Harasym, T. O., Tardi, P. G., Harasym, N. L., Shew, C. R., Johnstone, S. A., Ramsay, E. C., Janoff, A. S., Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice (2006) Molecular Cancer Therapeutics, 5 (7), pp. 1854-1863. , DOI 10. 1158/1535-7163. MCT-06-0118
Grant, C. W. M., Karlik, S., Florio, E., A liposomal MRI contrast agent: Phosphatidylethanolamine-DTPA (1989) Magnetic Resonance in Medicine, 11 (2), pp. 236-243
Koenig, S. H., Ahkong, Q. F., Brown Iii, R. D., Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions (1992) Magn. Reson. Med., 23 (2), pp. 275-286
Kabalka, G. W., Davis, M. A., Buonocore, E., Hubner, K., Holmberg, E., Huang, L., Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging (1990) Investigative Radiology, 25 (SUPPL. 1), pp. S63-S64
Kabalka, G. W., Buonocore, E., Hubner, K., Davis, M., Huang, L., Gadolinium-labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver (1988) Magn. Reson. Med., 8 (1), pp. 89-95
Kim, S. K., Pohost, G. M., Elgavish, G. A., Fatty-acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging (1991) Magn. Reson. Med., 22 (1), pp. 57-67
Torchilin, V. P., Antibody-modified liposomes for cancer chemotherapy (2008) Expert Opin. Drug Deliv., 5 (9), pp. 1003-1025
Wu, H., Chang, D. K., Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy (2010) J. Oncol., , DOI: 10. 1155/2010/723798 Epub ahead of print
Torchilin, V. P., Recent advances with liposomes as pharmaceutical carriers (2005) Nature Reviews Drug Discovery, 4 (2), pp. 145-160. , DOI 10. 1038/nrd1632
Allen, T. M., Ligand-targeted therapeutics in anticancer therapy (2002) Nature Reviews Cancer, 2 (10), pp. 750-763. , DOI 10. 1038/nrc903
Van Tilborg, G. A. F., Mulder, W. J. M., Deckers, N., Storm, G., Reutelingsperger, C. P. M., Strijkers, G. J., Nicolay, K., Annexin A5-functionalized bimodal lipid-based contrast agents for the detection of apoptosis (2006) Bioconjugate Chemistry, 17 (3), pp. 741-749. , DOI 10. 1021/bc0600259
Mulder, W. J. M., Strijkers, G. J., Van Tilborg Gaf, Cormode, D. P., Fayad, Z. A., Nicolay, K., Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging (2009) Acc. Chem. Res., 42 (7), pp. 904-914
Bull, S. R., Guler, M. O., Bras, R. E., Meade, T. J., Stupp, S. I., Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents (2005) Nano Letters, 5 (1), pp. 1-4. , DOI 10. 1021/nl0484898
Lipinski, M. J., Amirbekian, V., Frias, J. C., Aguinaldo, J. G. S., Mani, V., Briley-Saebo, K. C., Fuster, V., Fayad, Z. A., MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor (2006) Magnetic Resonance in Medicine, 56 (3), pp. 601-610. , DOI 10. 1002/mrm. 20995
Li, K. C. P., Bednarski, M. D., Vascular-targeted molecular imaging using functionalized polymerized vesicles (2002) Journal of Magnetic Resonance Imaging, 16 (4), pp. 388-393. , DOI 10. 1002/jmri. 10174
Storrs, R. W., Tropper, F. D., Li, H. Y., Paramagnetic polymerized liposomes: Synthesis, characterization, and applications for magnetic resonance imaging (1995) J. Am. Chem. Soc., 117 (28), pp. 7301-7306
Sipkins, D. A., Cheresh, D. A., Kazemi, M. R., Nevin, L. M., Bednarski, M. D., Li, K. C. P., Detection of tumor angiogenesis in vivo by (v) 3- targeted magnetic resonance imaging (1998) Nature Medicine, 4 (5), pp. 623-626. , DOI 10. 1038/nm0598-623
Sipkins, D. A., Gijbels, K., Tropper, F. D., Bednarski, M., Li, K. C. P., Steinman, L., ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging (2000) Journal of Neuroimmunology, 104 (1), pp. 1-9. , DOI 10. 1016/S0165-5728 (99) 00248-9, PII S0165572899002489
Brandwijk, R. J. M. G. E., Mulder, W. J. M., Nicolay, K., Mayo, K. H., Thijssen, V. L. J. L., Griffioen, A. W., Anginex-conjugated liposomes for targeting of angiogenic endothelial cells (2007) Bioconjugate Chemistry, 18 (3), pp. 785-790. , DOI 10. 1021/bc060316h
Wank, S. A., Cholecystokinin receptors (1995) The American journal of physiology, 269 (51), pp. G628-G646
Reubi, J. C., Schaer, J. -C., Waser, B., Cholecystokinin (CCK) -A and CCK-B/gastrin receptors in human tumors (1997) Cancer Research, 57 (7), pp. 1377-1386
Battey, J. F., Way, J. M., Corjay, M. H., Shapira, H., Kusano, K., Harkins, R., Wu, J. M., Feldman, R. I., Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (2), pp. 395-399
Nagalla, S. R., Barry, B. J., Creswick, K. C., Eden, P., Taylor, J. T., Cloning of a receptor for amphibian [Phe-13] bombesin distinct from the receptor for gastrin-releasing peptide: Identification of a fourth bombesin receptor subtype (BB4) (1995) Proc. Natl Acad. Sci. USA, 92 (13), pp. 6205-6209
Smith, C. J., Volkert, W. A., Hoffman, T. J., Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes (2005) Nuclear Medicine and Biology, 32 (7), pp. 733-740. , DOI 10. 1016/j. nucmedbio. 2005. 05. 005, PII S0969805105001423
Lamberts, S. W. J., Somatostatin analogues from one decade to the second (1999) Octreotide: The Next Decade, , Lamberts SWJ (Ed.) Bristol Bioscientifica, UK 3-65
Veber, D. F., Freidinger, R. M., Perlow, D. S., A potent cyclic hexapeptide analogue of somatostatin (1981) Nature, 292 (5818), pp. 55-58. , DOI 10. 1038/292055a0
Reubi, J. C., Waser, B., Schaer, J. C., Laissue, J. A., Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands Eur. J. Nucl. Med., 28, pp. 836-846. , Erratum in: Eur. J. Nucl. Med. 28, 1433 (2001)
Reubi, J. C., Horisberger, U., Laissue, J., High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction? (1994) International Journal of Cancer, 56 (5), pp. 681-688
Reubi, J. C., Peptide receptors as molecular targets for cancer diagnosis and therapy (2003) Endocrine Reviews, 24 (4), pp. 389-427. , DOI 10. 1210/er. 2002-0007
Anelli, P. L., Lattuada, L., Lorusso, V., Schneider, M., Tournier, H., Uggeri, F., Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents (2001) Magnetic Resonance Materials in Physics, Biology and Medicine, 12 (2-3), pp. 114-120. , DOI 10. 1016/S1352-8661 (01) 00107-7, PII S1352866101001077
Menger, F. M., Littau, C. A., Gemini-surfactants: Synthesis and properties (1991) J. Am. Chem. Soc., 113, pp. 1451-1452
Naposomes: A new class of peptide-derivatized, target-selective multimodal nanoparticles for imaging and therapeutic applications
Modified supramolecular aggregates for selective delivery of contrast agents and/or drugs are examined with a focus on a new class of peptide-derivatized nanoparticles: naposomes. These nanoparticles are based on the co-aggregation of two different amphiphilic monomers that give aggregates of different shapes and sizes (micelles, vesicles and liposomes) with diameters ranging between 10 and 300 nm. Structural properties and in vitro and in vivo behaviors are discussed. For the high relaxitivity values (12-19 mM -1s -1) and to detect for the presence of a surface-exposed peptide, the new peptide-derived supramolecular aggregates are very promising candidates as target-selective MRI contrast agents. The efficiency of surface-exposed peptides in homing these nanovectors to a specific target introduces promising new opportunities for the development of diagnostic and therapeutic agents with high specificity toward the biological target and reduced toxic side effects on nontarget organs. © 2011 Future Science Ltd.
Modified supramolecular aggregates for selective delivery of contrast agents and/or drugs are examined with a focus on a new class of peptide-derivatized nanoparticles: naposomes. These nanoparticles are based on the co-aggregation of two different amphiphilic monomers that give aggregates of different shapes and sizes (micelles, vesicles and liposomes) with diameters ranging between 10 and 300 nm. Structural properties and in vitro and in vivo behaviors are discussed. For the high relaxitivity values (12-19 mM -1s -1) and to detect for the presence of a surface-exposed peptide, the new peptide-derived supramolecular aggregates are very promising candidates as target-selective MRI contrast agents. The efficiency of surface-exposed peptides in homing these nanovectors to a specific target introduces promising new opportunities for the development of diagnostic and therapeutic agents with high specificity toward the biological target and reduced toxic side effects on nontarget organs. © 2011 Future Science Ltd.
Naposomes: A new class of peptide-derivatized, target-selective multimodal nanoparticles for imaging and therapeutic applications
No results. |
Naposomes: A new class of peptide-derivatized, target-selective multimodal nanoparticles for imaging and therapeutic applications
Other filter: ([btitle,keywords] "7-14 Bombesin" OR [b ...
Della Pepa R, Cerchione C, Pugliese N, Colicchio R, Salvatore P, Sirignano C, Soscia E, Pagano L, Sanguinetti M, Pane F, Picardi M
* Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1, 3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography (214 views) (PDF 14 views)
Supportive Care Cancer (ISSN: 0941-4355), 2018 Jun; 26(6): 1691-1694.
Impact Factor: 2.676
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (708 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Barresi V, Spampinato G, Musso N, Trovato Salinaro A, Rizzarelli E, Condorelli DF
* ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs (719 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2016; 156: 145-152.
Impact Factor: 3.348
View Export to BibTeX Export to EndNote
Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M
* Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (727 views)
Appl Microbiol Biot (ISSN: 0175-7598), 2014 Mar; 98(5): 1951-1961.
Impact Factor: 3.337
View Export to BibTeX Export to EndNote
Grasso GI, Arena G, Bellia F, Rizzarelli E, Vecchio G
* Copper(II)-chelating homocarnosine glycoconjugate as a new multifunctional compound (560 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2014 Feb; 131: 56-63.
Impact Factor: 3.444
View Export to BibTeX Export to EndNote
Dubbioso R, Pappata S, Quarantelli M, D'Arco F, Manganelli F, Esposito M, Santoro L
* Atypical Clinical And Radiological Presentation Of Cryptococcal Choroid Plexitis In An Immunocompetent Woman (380 views)
J Neurol Sci (ISSN: 1878-5883, 0022-510x), 2013 Nov; 334(1-2): 180-182.
Impact Factor: 1.453
View Export to BibTeX Export to EndNote
Calce E, Monfregola L, De Luca S
* Synthetic Strategy to Prepare DOTA-Based Bifunctional Chelating Agent Ready to Bind Biomolecular Probes (460 views)
Int J Pept Res Ther (ISSN: 1573-3149, 0929-5666), 2013 Sep; 19(3): 199-202.
Impact Factor: 0.825
View Export to BibTeX Export to EndNote
Di Fiore A, Maresca A, Supuran CT, De Simone G
* Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors (361 views)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2012; 48(70): 8838-8840.
Impact Factor: 6.378
View Export to BibTeX Export to EndNote
Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
* Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice (553 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2011 Mar 15; 6(3): e17971-e17971.
Impact Factor: 4.092
View Export to BibTeX Export to EndNote
Lanza V, Bellia F, D'Agata R, Grasso G, Rizzarelli E, Vecchio G
* New glycoside derivatives of carnosine and analogs resistant to carnosinase hydrolysis: synthesis and characterization of their copper(II) complexes (402 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2011 Feb; 105(2): 181-188.
Impact Factor: 3.354
View Export to BibTeX Export to EndNote
Digilio G, Menchise V, Gianolio E, Catanzaro V, Carrera C, Napolitano R, Fedeli F, Aime S
* Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling (455 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jul 8; 53(13): 4877-4890.
Impact Factor: 5.207
View Export to BibTeX Export to EndNote
Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D, Radulescu A, Aurilio M, Aloj L, Arra C, Morelli G
* Peptide modified nanocarriers for selective targeting of bombesin receptors (429 views)
Mol Biosyst (ISSN: 1742-206x), 2010 May; 6(5): 878-887.
Impact Factor: 3.825
View Export to BibTeX Export to EndNote
Arnesano F, Scintilla S, Calò V, Bonfrate E, Ingrosso C, Losacco M, Pellegrino T, Rizzarelli E, Natile G
* Copper-triggered aggregation of ubiquitin (533 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2009 Sep 16; 4(9): e7052-e7052.
Impact Factor: 4.351
View Export to BibTeX Export to EndNote
Accardo A, Tesauro D, Morisco A, Mangiapia G, Vaccaro M, Gianolio E, Heenan RK, Paduano L, Morelli G
* Micelles obtained by aggregation of gemini surfactants containing the CCK8 peptide and a gadolinium complex (398 views)
J Biol Inorg Chem (ISSN: 0949-8257, 1432-1327electronic, 0949-8257linking), 2009 May; 14(4): 587-599.
Impact Factor: 3.415
View Export to BibTeX Export to EndNote
Ciaccio C, Tundo GR, Grasso G, Spoto G, Marasco D, Ruvo M, Gioia M, Rizzarelli E, Coletta M
* Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity (454 views)
J Mol Biol (ISSN: 1089-8638, 0022-2836, 1089-8638electronic), 2009 Feb 6; 385(5): 1556-1567.
Impact Factor: 3.871
View Export to BibTeX Export to EndNote
Vaccaro M, Mangiapia G, Accardo A, Tesauro D, Gianolio E, Frielinghaus H, Morelli G, Paduano L
* Polymerized mixed aggregates containing gadolinium complex and CCK8 peptide (423 views)
Colloid Polym Sci (ISSN: 0303-402x), 2008 Dec; 286(14-15): 1643-1652.
Impact Factor: 1.736
View Export to BibTeX Export to EndNote
Accardo A, Tesauro D, Del Pozzo L, Mangiapia G, Paduano L, Morelli G
* Micelles by self-assembling peptide-conjugate amphiphile: Synthesis and structural characterization (402 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): 903-910.
Impact Factor: 1.654
View Export to BibTeX Export to EndNote
D'Andrea LD, Testa I, Panico M, Di Stasi R, Carac C, Tarallo L, Arra C, Barbieri A, Romanelli A, Aloj L
* In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with Tc-99m-tricarbonyl (424 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2008; 90(5): 707-712.
Impact Factor: 2.823
View Export to BibTeX Export to EndNote
De Luca S, De Capua A, Saviano M, Della Moglie R, Aloj L, Tarallo L, Pedone C, Morelli G
* Synthesis and biological evaluation of cyclic and branched peptide analogues as ligands for cholecystokinin type 1 receptor (398 views)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 1464-3391electronic), 2007 Sep 1; 15(17): 5845-5853.
Impact Factor: 2.662
View Export to BibTeX Export to EndNote
Vaccaro M, Accardo A, D'Errico G, Schillen K, Radulescu A, Tesauro D, Morelli G, Paduano L
* Peptides and gd complexes containing colloidal assemblies as tumor-specific contrast agents in MRI: Physicochemical characterization (399 views)
Biophysical Journal (ISSN: 0006-3495, 1542-0086), 2007 Sep; 93(5): 1736-1746.
Impact Factor: 4.627
View Export to BibTeX Export to EndNote
Tesauro D, Accardo A, Gianolio E, Paduano L, Teixeira J, Schillén K, Aime S, Morelli G
* Peptide derivatized lamellar aggregates as target-specific MRI contrast agents (580 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2007 May 25; 8(8): 950-955.
Impact Factor: 3.446
View Export to BibTeX Export to EndNote
Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, Di Paola R, Muià C, La Rosa C, Crimi N, Rizzarelli E, Vancheri C
* Protective effect of orally administered carnosine on bleomycin-induced lung injury (575 views)
Am J Physiol Lung Cell Mol Physiol (ISSN: 1040-0605), 2007 May; 292(5): L1095-L1095.
Impact Factor: 4.214
View Export to BibTeX Export to EndNote
Accardo A, Tesauro D, Morelli G, Gianolio E, Aime S, Vaccaro M, Mangiapia G, Paduano L, Schillén K
* High-relaxivity supramolecular aggregates containing peptides and Gd complexes as contrast agents in MRI (423 views)
J Biol Inorg Chem (ISSN: 0949-8257, 1432-1327electronic, 0949-8257print), 2007 Feb; 12(2): 267-276.
Impact Factor: 3.325
View Export to BibTeX Export to EndNote
De Luca S, Saviano M, Lassiani L, Yannakopoulou K, Stefanidou P, Aloj L, Morelli G, Varnavas A
* Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their "receptor desmodynamic processes" (438 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Apr 20; 49(8): 2456-2462.
Impact Factor: 5.115
View Export to BibTeX Export to EndNote
De Luca S, Sanseverino M, Zocchi I, Pedone C, Morelli G, Ragone R
* Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: A fluorescence study on type B receptor fragment CCKB-R (352-379) (359 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2005 Mar; 77(4): 205-211.
Impact Factor: 2.545
View Export to BibTeX Export to EndNote
De Luca S, Morelli G
* Synthesis and characterization of a sulfated and a non-sulfated cyclic CCK8 analogue functionalized with a chelating group for metal labelling (395 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2004 May; 10(5): 265-273.
Impact Factor: 1.652
View Export to BibTeX Export to EndNote
Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (472 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
View Export to BibTeX Export to EndNote
De Luca S, Ragone R, Bracco C, Digilio G, Aloj L, Tesauro D, Saviano M, Pedone C, Morelli G
* A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements (472 views)
Chembiochem (ISSN: 1439-7633, 1439-4227, 1439-7633electronic), 2003 Nov 7; 4(11): 1176-1187.
Impact Factor: 3.992
View Export to BibTeX Export to EndNote
Morelli G, De Luca S, Tesauro D, Saviano M, Pedone C, Dolmella A, Visentin R, Mazzi U
* CCK8 peptide derivatized with diphenylphosphine for rhenium labelling: Synthesis and molecular mechanics calculations (323 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2002 Jul; 8(7): 373-381.
Impact Factor: 1.691
View Export to BibTeX Export to EndNote
De Luca S, Tesauro D, Di Lello P, Fattorusso R, Saviano M, Pedone C, Morelli G
* Synthesis and solution characterization of a porphyrin-CCK8 conjugate (443 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2001 Jul; 7(7): 386-394.
Impact Factor: 1.451
View Export to BibTeX Export to EndNote
* Diagnostic-driven antifungal approach in neutropenic patients at high risk for chronic disseminated candidiasis: preliminary observations on the role of 1, 3-ß-D-glucan antigenemia and multiphasic contrast-enhanced computed tomography (214 views) (PDF 14 views)
Supportive Care Cancer (ISSN: 0941-4355), 2018 Jun; 26(6): 1691-1694.
Impact Factor: 2.676
View Export to BibTeX Export to EndNote
Lanza V, Milardi D, Di Natale G, Pappalardo G
* Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases (708 views)
Curr Med Chem (ISSN: 1875-533xelectronic, 0929-8673linking), 2018 Feb 12; 25(4): 525-539.
Impact Factor: 3.249
View Export to BibTeX Export to EndNote
Barresi V, Spampinato G, Musso N, Trovato Salinaro A, Rizzarelli E, Condorelli DF
* ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs (719 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2016; 156: 145-152.
Impact Factor: 3.348
View Export to BibTeX Export to EndNote
Rai M, Kon K, Ingle A, Duran N, Galdiero S, Galdiero M
* Broad-spectrum bioactivities of silver nanoparticles: the emerging trends and future prospects (727 views)
Appl Microbiol Biot (ISSN: 0175-7598), 2014 Mar; 98(5): 1951-1961.
Impact Factor: 3.337
View Export to BibTeX Export to EndNote
Grasso GI, Arena G, Bellia F, Rizzarelli E, Vecchio G
* Copper(II)-chelating homocarnosine glycoconjugate as a new multifunctional compound (560 views)
J Chem Res (ISSN: 0162-0134, 1873-3344, 0162-0134print), 2014 Feb; 131: 56-63.
Impact Factor: 3.444
View Export to BibTeX Export to EndNote
Dubbioso R, Pappata S, Quarantelli M, D'Arco F, Manganelli F, Esposito M, Santoro L
* Atypical Clinical And Radiological Presentation Of Cryptococcal Choroid Plexitis In An Immunocompetent Woman (380 views)
J Neurol Sci (ISSN: 1878-5883, 0022-510x), 2013 Nov; 334(1-2): 180-182.
Impact Factor: 1.453
View Export to BibTeX Export to EndNote
Calce E, Monfregola L, De Luca S
* Synthetic Strategy to Prepare DOTA-Based Bifunctional Chelating Agent Ready to Bind Biomolecular Probes (460 views)
Int J Pept Res Ther (ISSN: 1573-3149, 0929-5666), 2013 Sep; 19(3): 199-202.
Impact Factor: 0.825
View Export to BibTeX Export to EndNote
Di Fiore A, Maresca A, Supuran CT, De Simone G
* Hydroxamate represents a versatile zinc binding group for the development of new carbonic anhydrase inhibitors (361 views)
Chem Commun (ISSN: 1359-7345, 1364-548x, 1364-548xelectronic), 2012; 48(70): 8838-8840.
Impact Factor: 6.378
View Export to BibTeX Export to EndNote
Corona C, Frazzini V, Silvestri E, Lattanzio R, La Sorda R, Piantelli M, Canzoniero LM, Ciavardelli D, Rizzarelli E, Sensi SL
* Effects of dietary supplementation of carnosine on mitochondrial dysfunction, amyloid pathology, and cognitive deficits in 3xTg-AD mice (553 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2011 Mar 15; 6(3): e17971-e17971.
Impact Factor: 4.092
View Export to BibTeX Export to EndNote
Lanza V, Bellia F, D'Agata R, Grasso G, Rizzarelli E, Vecchio G
* New glycoside derivatives of carnosine and analogs resistant to carnosinase hydrolysis: synthesis and characterization of their copper(II) complexes (402 views)
J Chem Res (ISSN: 1873-3344, 0162-0134, 0162-0134print), 2011 Feb; 105(2): 181-188.
Impact Factor: 3.354
View Export to BibTeX Export to EndNote
Digilio G, Menchise V, Gianolio E, Catanzaro V, Carrera C, Napolitano R, Fedeli F, Aime S
* Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling (455 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2010 Jul 8; 53(13): 4877-4890.
Impact Factor: 5.207
View Export to BibTeX Export to EndNote
Accardo A, Mansi R, Morisco A, Mangiapia G, Paduano L, Tesauro D, Radulescu A, Aurilio M, Aloj L, Arra C, Morelli G
* Peptide modified nanocarriers for selective targeting of bombesin receptors (429 views)
Mol Biosyst (ISSN: 1742-206x), 2010 May; 6(5): 878-887.
Impact Factor: 3.825
View Export to BibTeX Export to EndNote
Arnesano F, Scintilla S, Calò V, Bonfrate E, Ingrosso C, Losacco M, Pellegrino T, Rizzarelli E, Natile G
* Copper-triggered aggregation of ubiquitin (533 views)
Plosone (ISSN: 1932-6203, 1932-6203electronic, 1932-6203linking), 2009 Sep 16; 4(9): e7052-e7052.
Impact Factor: 4.351
View Export to BibTeX Export to EndNote
Accardo A, Tesauro D, Morisco A, Mangiapia G, Vaccaro M, Gianolio E, Heenan RK, Paduano L, Morelli G
* Micelles obtained by aggregation of gemini surfactants containing the CCK8 peptide and a gadolinium complex (398 views)
J Biol Inorg Chem (ISSN: 0949-8257, 1432-1327electronic, 0949-8257linking), 2009 May; 14(4): 587-599.
Impact Factor: 3.415
View Export to BibTeX Export to EndNote
Ciaccio C, Tundo GR, Grasso G, Spoto G, Marasco D, Ruvo M, Gioia M, Rizzarelli E, Coletta M
* Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity (454 views)
J Mol Biol (ISSN: 1089-8638, 0022-2836, 1089-8638electronic), 2009 Feb 6; 385(5): 1556-1567.
Impact Factor: 3.871
View Export to BibTeX Export to EndNote
Vaccaro M, Mangiapia G, Accardo A, Tesauro D, Gianolio E, Frielinghaus H, Morelli G, Paduano L
* Polymerized mixed aggregates containing gadolinium complex and CCK8 peptide (423 views)
Colloid Polym Sci (ISSN: 0303-402x), 2008 Dec; 286(14-15): 1643-1652.
Impact Factor: 1.736
View Export to BibTeX Export to EndNote
Accardo A, Tesauro D, Del Pozzo L, Mangiapia G, Paduano L, Morelli G
* Micelles by self-assembling peptide-conjugate amphiphile: Synthesis and structural characterization (402 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2008 Sep; 14(8): 903-910.
Impact Factor: 1.654
View Export to BibTeX Export to EndNote
D'Andrea LD, Testa I, Panico M, Di Stasi R, Carac C, Tarallo L, Arra C, Barbieri A, Romanelli A, Aloj L
* In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with Tc-99m-tricarbonyl (424 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2008; 90(5): 707-712.
Impact Factor: 2.823
View Export to BibTeX Export to EndNote
De Luca S, De Capua A, Saviano M, Della Moglie R, Aloj L, Tarallo L, Pedone C, Morelli G
* Synthesis and biological evaluation of cyclic and branched peptide analogues as ligands for cholecystokinin type 1 receptor (398 views)
Bioorg Med Chem (ISSN: 0968-0896, 1464-3391, 1464-3391electronic), 2007 Sep 1; 15(17): 5845-5853.
Impact Factor: 2.662
View Export to BibTeX Export to EndNote
Vaccaro M, Accardo A, D'Errico G, Schillen K, Radulescu A, Tesauro D, Morelli G, Paduano L
* Peptides and gd complexes containing colloidal assemblies as tumor-specific contrast agents in MRI: Physicochemical characterization (399 views)
Biophysical Journal (ISSN: 0006-3495, 1542-0086), 2007 Sep; 93(5): 1736-1746.
Impact Factor: 4.627
View Export to BibTeX Export to EndNote
Tesauro D, Accardo A, Gianolio E, Paduano L, Teixeira J, Schillén K, Aime S, Morelli G
* Peptide derivatized lamellar aggregates as target-specific MRI contrast agents (580 views)
Chembiochem (ISSN: 1439-4227, 1439-7633, 1439-7633electronic), 2007 May 25; 8(8): 950-955.
Impact Factor: 3.446
View Export to BibTeX Export to EndNote
Cuzzocrea S, Genovese T, Failla M, Vecchio G, Fruciano M, Mazzon E, Di Paola R, Muià C, La Rosa C, Crimi N, Rizzarelli E, Vancheri C
* Protective effect of orally administered carnosine on bleomycin-induced lung injury (575 views)
Am J Physiol Lung Cell Mol Physiol (ISSN: 1040-0605), 2007 May; 292(5): L1095-L1095.
Impact Factor: 4.214
View Export to BibTeX Export to EndNote
Accardo A, Tesauro D, Morelli G, Gianolio E, Aime S, Vaccaro M, Mangiapia G, Paduano L, Schillén K
* High-relaxivity supramolecular aggregates containing peptides and Gd complexes as contrast agents in MRI (423 views)
J Biol Inorg Chem (ISSN: 0949-8257, 1432-1327electronic, 0949-8257print), 2007 Feb; 12(2): 267-276.
Impact Factor: 3.325
View Export to BibTeX Export to EndNote
De Luca S, Saviano M, Lassiani L, Yannakopoulou K, Stefanidou P, Aloj L, Morelli G, Varnavas A
* Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their "receptor desmodynamic processes" (438 views)
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Apr 20; 49(8): 2456-2462.
Impact Factor: 5.115
View Export to BibTeX Export to EndNote
De Luca S, Sanseverino M, Zocchi I, Pedone C, Morelli G, Ragone R
* Receptor fragment approach to the binding between CCK8 peptide and cholecystokinin receptors: A fluorescence study on type B receptor fragment CCKB-R (352-379) (359 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2005 Mar; 77(4): 205-211.
Impact Factor: 2.545
View Export to BibTeX Export to EndNote
De Luca S, Morelli G
* Synthesis and characterization of a sulfated and a non-sulfated cyclic CCK8 analogue functionalized with a chelating group for metal labelling (395 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2004 May; 10(5): 265-273.
Impact Factor: 1.652
View Export to BibTeX Export to EndNote
Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (472 views)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
View Export to BibTeX Export to EndNote
De Luca S, Ragone R, Bracco C, Digilio G, Aloj L, Tesauro D, Saviano M, Pedone C, Morelli G
* A cyclic CCK8 analogue selective for the cholecystokinin type A receptor: design, synthesis, NMR structure and binding measurements (472 views)
Chembiochem (ISSN: 1439-7633, 1439-4227, 1439-7633electronic), 2003 Nov 7; 4(11): 1176-1187.
Impact Factor: 3.992
View Export to BibTeX Export to EndNote
Morelli G, De Luca S, Tesauro D, Saviano M, Pedone C, Dolmella A, Visentin R, Mazzi U
* CCK8 peptide derivatized with diphenylphosphine for rhenium labelling: Synthesis and molecular mechanics calculations (323 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2002 Jul; 8(7): 373-381.
Impact Factor: 1.691
View Export to BibTeX Export to EndNote
De Luca S, Tesauro D, Di Lello P, Fattorusso R, Saviano M, Pedone C, Morelli G
* Synthesis and solution characterization of a porphyrin-CCK8 conjugate (443 views)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2001 Jul; 7(7): 386-394.
Impact Factor: 1.451
View Export to BibTeX Export to EndNote
30 Records (27 excluding Abstracts).
Total impact factor: 96.621 (83.964 excluding Abstracts).
Total 5 year impact factor: 97.161 (83.983 excluding Abstracts).
Total impact factor: 96.621 (83.964 excluding Abstracts).
Total 5 year impact factor: 97.161 (83.983 excluding Abstracts).
408 views. Last view on Thursday 23 February 2023, 7:16:22
ibb.cnr.it
